Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
SST vs ACMR vs ICHR vs TPVG vs MKSI
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Asset Management
Hardware, Equipment & Parts
SST vs ACMR vs ICHR vs TPVG vs MKSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Semiconductors | Semiconductors | Asset Management | Hardware, Equipment & Parts |
| Market Cap | $32M | $3.96B | $2.59B | $234M | $21.09B |
| Revenue (TTM) | $266M | $960M | $959M | $97M | $4.07B |
| Net Income (TTM) | $-65M | $91M | $-51M | $-12M | $327M |
| Gross Margin | 37.7% | 44.2% | 11.3% | 83.5% | 45.2% |
| Operating Margin | -23.3% | 12.5% | -3.8% | 77.9% | 14.8% |
| Forward P/E | — | 30.8x | 54.0x | 6.2x | 27.3x |
| Total Debt | $10M | $303M | $186M | $469M | $4.69B |
| Cash & Equiv. | $87M | $766M | $98M | $20M | $675M |
SST vs ACMR vs ICHR vs TPVG vs MKSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 20 | May 26 | Return |
|---|---|---|---|
| System1, Inc. (SST) | 100 | 3.9 | -96.1% |
| ACM Research, Inc. (ACMR) | 100 | 202.2 | +102.2% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 295.8 | +195.8% |
| TriplePoint Venture… (TPVG) | 100 | 51.3 | -48.7% |
| MKS Inc. (MKSI) | 100 | 262.0 | +162.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SST vs ACMR vs ICHR vs TPVG vs MKSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, SST doesn't own a clear edge in any measured category.
ACMR is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- 31.0% 10Y total return vs MKSI's 7.8%
- Lower volatility, beta 3.17, Low D/E 15.7%, current ratio 3.27x
- PEG 0.87 vs TPVG's 6.14
ICHR ranks third and is worth considering specifically for momentum.
- +345.1% vs SST's -3.7%
TPVG carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 0 yrs, beta 0.77, yield 17.8%
- Beta 0.77, yield 17.8%
- 36.6% NII/revenue growth vs SST's -22.6%
- 50.6% margin vs SST's -24.6%
MKSI is the clearest fit if your priority is efficiency.
- 3.7% ROA vs SST's -16.0%, ROIC 6.5% vs -39.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.6% NII/revenue growth vs SST's -22.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 50.6% margin vs SST's -24.6% | |
| Stability / Safety | Beta 0.77 vs ICHR's 3.78 | |
| Dividends | 17.8% yield, vs ACMR's 0.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +345.1% vs SST's -3.7% | |
| Efficiency (ROA) | 3.7% ROA vs SST's -16.0%, ROIC 6.5% vs -39.3% |
SST vs ACMR vs ICHR vs TPVG vs MKSI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
SST vs ACMR vs ICHR vs TPVG vs MKSI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TPVG leads in 1 of 6 categories
ACMR leads 1 • SST leads 0 • ICHR leads 0 • MKSI leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TPVG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MKSI is the larger business by revenue, generating $4.1B annually — 41.9x TPVG's $97M. TPVG is the more profitable business, keeping 50.6% of every revenue dollar as net income compared to SST's -24.6%. On growth, ACMR holds the edge at +34.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $266M | $960M | $959M | $97M | $4.1B |
| EBITDAEarnings before interest/tax | $21M | $133M | -$11M | -$22M | $945M |
| Net IncomeAfter-tax profit | -$65M | $91M | -$51M | -$12M | $327M |
| Free Cash FlowCash after capex | -$11M | -$108M | -$17M | -$59M | $401M |
| Gross MarginGross profit ÷ Revenue | +37.7% | +44.2% | +11.3% | +83.5% | +45.2% |
| Operating MarginEBIT ÷ Revenue | -23.3% | +12.5% | -3.8% | +77.9% | +14.8% |
| Net MarginNet income ÷ Revenue | -24.6% | +9.5% | -5.3% | +50.6% | +8.0% |
| FCF MarginFCF ÷ Revenue | -4.0% | -11.3% | -1.7% | -58.7% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -31.3% | +34.2% | +4.7% | — | +15.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.8% | -20.0% | +46.2% | -2.3% | +53.2% |
Valuation Metrics
Evenly matched — SST and TPVG each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 4.7x trailing earnings, TPVG trades at a 93% valuation discount to MKSI's 71.7x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.23x vs TPVG's 4.67x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $32M | $4.0B | $2.6B | $234M | $21.1B |
| Enterprise ValueMkt cap + debt − cash | -$46M | $3.5B | $2.7B | $683M | $25.1B |
| Trailing P/EPrice ÷ TTM EPS | -0.47x | 43.69x | -48.32x | 4.73x | 71.67x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 30.81x | 53.98x | 6.23x | 27.27x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.23x | — | 4.67x | — |
| EV / EBITDAEnterprise value multiple | -2.19x | 27.83x | — | 9.02x | 27.62x |
| Price / SalesMarket cap ÷ Revenue | 0.12x | 4.40x | 2.73x | 2.41x | 5.36x |
| Price / BookPrice ÷ Book value/share | 1.77x | 2.09x | 3.84x | 0.66x | 7.80x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | 42.43x |
Profitability & Efficiency
Evenly matched — ACMR and MKSI each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-151 for SST. ACMR carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), MKSI scores 6/9 vs ACMR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -151.3% | +5.1% | -7.5% | -3.4% | +12.2% |
| ROA (TTM)Return on assets | -16.0% | +3.4% | -5.2% | -1.5% | +3.7% |
| ROICReturn on invested capital | -39.3% | +7.0% | -3.9% | +7.2% | +6.5% |
| ROCEReturn on capital employed | -20.3% | +6.6% | -4.7% | +9.4% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 | 3 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.55x | 0.16x | 0.28x | 1.33x | 1.73x |
| Net DebtTotal debt minus cash | -$77M | -$463M | $87M | $449M | $4.0B |
| Cash & Equiv.Liquid assets | $87M | $766M | $98M | $20M | $675M |
| Total DebtShort + long-term debt | $10M | $303M | $186M | $469M | $4.7B |
| Interest CoverageEBIT ÷ Interest expense | -2.25x | 20.41x | -5.97x | -1.02x | 2.84x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $26,731 today (with dividends reinvested), compared to $394 for SST. Over the past 12 months, ICHR leads with a +345.1% total return vs SST's -3.7%. The 3-year compound annual growth rate (CAGR) favors ACMR at 81.1% vs SST's -50.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -8.4% | +33.4% | +264.6% | -9.6% | +86.2% |
| 1-Year ReturnPast 12 months | -3.7% | +166.8% | +345.1% | +7.4% | +306.4% |
| 3-Year ReturnCumulative with dividends | -87.6% | +494.3% | +162.3% | -5.6% | +281.0% |
| 5-Year ReturnCumulative with dividends | -96.1% | +167.3% | +46.0% | -15.2% | +82.1% |
| 10-Year ReturnCumulative with dividends | -95.7% | +3100.5% | +661.7% | +91.2% | +784.8% |
| CAGR (3Y)Annualised 3-year return | -50.1% | +81.1% | +37.9% | -1.9% | +56.2% |
Risk & Volatility
Evenly matched — ICHR and TPVG each lead in 1 of 2 comparable metrics.
Risk & Volatility
TPVG is the less volatile stock with a 0.77 beta — it tends to amplify market swings less than ICHR's 3.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 98.8% from its 52-week high vs SST's 26.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.52x | 3.17x | 3.78x | 0.77x | 2.56x |
| 52-Week HighHighest price in past year | $15.00 | $71.65 | $75.35 | $7.53 | $326.83 |
| 52-Week LowLowest price in past year | $1.35 | $19.76 | $13.12 | $4.48 | $73.21 |
| % of 52W HighCurrent price vs 52-week peak | +26.1% | +83.5% | +98.8% | +76.6% | +95.8% |
| RSI (14)Momentum oscillator 0–100 | 56.0 | 66.3 | 64.2 | 67.6 | 68.0 |
| Avg Volume (50D)Average daily shares traded | 4.0M | 1.1M | 791K | 501K | 1.2M |
Analyst Outlook
Evenly matched — ACMR and TPVG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SST as "Buy", ACMR as "Buy", ICHR as "Buy", TPVG as "Hold", MKSI as "Buy". Consensus price targets imply 269.9% upside for SST (target: $15) vs -26.6% for ICHR (target: $55). For income investors, TPVG offers the higher dividend yield at 17.76% vs SST's 0.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $14.50 | $75.00 | $54.60 | $8.95 | $294.25 |
| # AnalystsCovering analysts | 4 | 10 | 14 | 12 | 29 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +0.2% | — | +17.8% | +0.3% |
| Dividend StreakConsecutive years of raises | 1 | 3 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.00 | $0.11 | — | $1.02 | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +0.2% | 0.0% | 0.0% | +0.2% |
TPVG leads in 1 of 6 categories (Income & Cash Flow). ACMR leads in 1 (Total Returns). 4 tied.
SST vs ACMR vs ICHR vs TPVG vs MKSI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SST or ACMR or ICHR or TPVG or MKSI a better buy right now?
For growth investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger pick with 36. 6% revenue growth year-over-year, versus -22. 6% for System1, Inc. (SST). TriplePoint Venture Growth BDC Corp. (TPVG) offers the better valuation at 4. 7x trailing P/E (6. 2x forward), making it the more compelling value choice. Analysts rate System1, Inc. (SST) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SST or ACMR or ICHR or TPVG or MKSI?
On trailing P/E, TriplePoint Venture Growth BDC Corp.
(TPVG) is the cheapest at 4. 7x versus MKS Inc. at 71. 7x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 87x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SST or ACMR or ICHR or TPVG or MKSI?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +167. 3%, compared to -96. 1% for System1, Inc. (SST). Over 10 years, the gap is even starker: ACMR returned +31. 0% versus SST's -95. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SST or ACMR or ICHR or TPVG or MKSI?
By beta (market sensitivity over 5 years), TriplePoint Venture Growth BDC Corp.
(TPVG) is the lower-risk stock at 0. 77β versus Ichor Holdings, Ltd. 's 3. 78β — meaning ICHR is approximately 391% more volatile than TPVG relative to the S&P 500. On balance sheet safety, ACM Research, Inc. (ACMR) carries a lower debt/equity ratio of 16% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SST or ACMR or ICHR or TPVG or MKSI?
By revenue growth (latest reported year), TriplePoint Venture Growth BDC Corp.
(TPVG) is pulling ahead at 36. 6% versus -22. 6% for System1, Inc. (SST). On earnings-per-share growth, the picture is similar: MKS Inc. grew EPS 55. 5% year-over-year, compared to -677. 6% for System1, Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SST or ACMR or ICHR or TPVG or MKSI?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus -24. 6% for System1, Inc. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -23. 3% for SST. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SST or ACMR or ICHR or TPVG or MKSI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 87x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 2x forward P/E versus 54. 0x for Ichor Holdings, Ltd. — 47. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SST: 269. 9% to $14. 50.
08Which pays a better dividend — SST or ACMR or ICHR or TPVG or MKSI?
In this comparison, TPVG (17.
8% yield), MKSI (0. 3% yield), ACMR (0. 2% yield), SST (0. 1% yield) pay a dividend. ICHR does not pay a meaningful dividend and should not be held primarily for income.
09Is SST or ACMR or ICHR or TPVG or MKSI better for a retirement portfolio?
For long-horizon retirement investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 77), 17. 8% yield). ACM Research, Inc. (ACMR) carries a higher beta of 3. 17 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TPVG: +91. 2%, ACMR: +31. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SST and ACMR and ICHR and TPVG and MKSI?
These companies operate in different sectors (SST (Industrials) and ACMR (Technology) and ICHR (Technology) and TPVG (Financial Services) and MKSI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SST is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock; TPVG is a small-cap high-growth stock; MKSI is a mid-cap quality compounder stock. TPVG pays a dividend while SST, ACMR, ICHR, MKSI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.